BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lyu J, Li T, Wang Q, Li F, Diao P, Liu L, Li C, Lang J. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study. Radiat Oncol 2018;13:233. [PMID: 30477531 DOI: 10.1186/s13014-018-1183-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Li C, Wang Z, Duan A, Jiang Q. Analysis on plausible factors related to the prognosis of stage IV esophageal cancer. Medicine (Baltimore) 2020;99:e18529. [PMID: 32195923 DOI: 10.1097/MD.0000000000018529] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Liu H, Zhang J, Luo X, Zeng M, Xu L, Zhang Q, Liu H, Guo J, Xu L. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis. Oncol Res 2020;28:65-73. [PMID: 31558183 DOI: 10.3727/096504019X15656904013079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
3 Zhang S, Guo J, Zhang H, Li H, Hassan MOO, Zhang L. Metastasis pattern and prognosis in men with esophageal cancer patients: A SEER-based study. Medicine (Baltimore) 2021;100:e26496. [PMID: 34160464 DOI: 10.1097/MD.0000000000026496] [Reference Citation Analysis]
4 Shi Z, Zhu X, Ke S, Qiu H, Cai G, Zhangcai Y, Chen Y. Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses. Radiother Oncol 2021;164:236-44. [PMID: 34627936 DOI: 10.1016/j.radonc.2021.09.033] [Reference Citation Analysis]